Vimarsana
Biggest News Aggregation in the World

Page 19 - Early Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Early Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Early Phase Today - Breaking & Trending Today

Personalized Cancer Vaccine Guided by Mount Sinai Computations Is Safe, Shows Potential Benefit Against Multiple Tumor Types - Vimarsana News

Personalized Cancer Vaccine Guided by Mount Sinai Computations Is Safe, Shows Potential Benefit Against Multiple Tumor Types

Personalized Cancer Vaccine Guided by Mount Sinai Computations Is Safe, Shows Potential Benefit Against Multiple Tumor Types Share Article A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15. ...

Source: prweb.com
Personalized cancer vaccine is safe, shows potential benefit against cancer - Vimarsana News

Personalized cancer vaccine is safe, shows potential benefit against cancer

 E-Mail New York, NY (April 10, 2021) - A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15. "While immunotherapy has revolutionized the treatment of cancer, the vast majority of patients do not experience a si...

Quotient acquisition of Arcinova aimed at 'streamlining' early development process for biotech and pharma companies - Vimarsana News

Quotient acquisition of Arcinova aimed at 'streamlining' early development process for biotech and pharma companies

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO). Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide. It has been in business for over 40 years.  The combined business will continue to focus on both biotech firms ...

How Did Agri-start-ups Fare during the COVID-19 Pandemic? : Challenges and the Way Forward - Vimarsana News

How Did Agri-start-ups Fare during the COVID-19 Pandemic? : Challenges and the Way Forward

Although agricultural start-ups in India took a hit due to the COVID-19-induced lockdown, they have enormous potential in aiding economic recovery. A survey of 162 start-ups from 29 states, located in 98 cities, reveals that many start-ups have tailored their products, modified their technologies and invested in their long-term growth potential, even as they suffered from liquidity crunch, lack of investor funds and poor demand. The government should provide capital access, market access support and end-to-end solutions for innovation and marketing towards harnessing the power of these start...

Source: epw.in
Star Wars: Diese neuen Serien plant Disney+ - Vimarsana News

Star Wars: Diese neuen Serien plant Disney+

Den Investor Day nutzten Disney und Lucasfilm für die Verkündung zahlreicher neuer Star-Wars-Projekte. Bereits bekannt waren Serien zu Cassian Andor, Obi-Wan Kenobi und dem Bad Batch. Doch das war längst nicht alles...